Literature DB >> 16223956

Mycoplasmas and ureaplasmas as neonatal pathogens.

Ken B Waites1, Brenda Katz, Robert L Schelonka.   

Abstract

The genital mycoplasmas represent a complex and unique group of microorganisms that have been associated with a wide array of infectious diseases in adults and infants. The lack of conclusive knowledge regarding the pathogenic potential of Mycoplasma and Ureaplasma spp. in many conditions is due to a general unfamiliarity of physicians and microbiology laboratories with their fastidious growth requirements, leading to difficulty in their detection; their high prevalence in healthy persons; the poor design of research studies attempting to base association with disease on the mere presence of the organisms in the lower urogenital tract; the failure to consider multifactorial aspects of diseases; and considering these genital mycoplasmas only as a last resort. The situation is now changing because of a greater appreciation of the genital mycoplasmas as perinatal pathogens and improvements in laboratory detection, particularly with regard to the development of powerful molecular nucleic acid amplification tests. This review summarizes the epidemiology of genital mycoplasmas as causes of neonatal infections and premature birth; evidence linking ureaplasmas with bronchopulmonary dysplasia; recent changes in the taxonomy of the genus Ureaplasma; the neonatal host response to mycoplasma and ureaplasma infections; advances in laboratory detection, including molecular methods; and therapeutic considerations for treatment of systemic diseases.

Entities:  

Mesh:

Year:  2005        PMID: 16223956      PMCID: PMC1265909          DOI: 10.1128/CMR.18.4.757-789.2005

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  327 in total

1.  Simple method for determining biovar and serovar types of Ureaplasma urealyticum clinical isolates using PCR-single-strand conformation polymorphism analysis.

Authors:  D Pitcher; M Sillis; J A Robertson
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 2.  Structure, function, and assembly of the terminal organelle of Mycoplasma pneumoniae.

Authors:  D C Krause; M F Balish
Journal:  FEMS Microbiol Lett       Date:  2001-04-20       Impact factor: 2.742

3.  Is Mycoplasma hominis a vaginal pathogen?

Authors:  O P Arya; C Y Tong; C A Hart; B C Pratt; S Hughes; P Roberts; P Kirby; J Howel; A McCormick; A D Goddard
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

4.  Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group.

Authors:  S L Kenyon; D J Taylor; W Tarnow-Mordi
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

5.  Plasminogen binding and activation by Mycoplasma fermentans.

Authors:  A Yavlovich; A A Higazi; S Rottem
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease.

Authors:  P Groneck; J Schmale; V Soditt; H Stützer; B Götze-Speer; C P Speer
Journal:  Pediatr Pulmonol       Date:  2001-05

7.  Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults.

Authors:  W M Manimtim; J D Hasday; L Hester; K D Fairchild; J C Lovchik; R M Viscardi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  The value of Ureaplasma urealyticum tracheal culture and treatment in premature infants following an acute respiratory deterioration.

Authors:  Maroun J Mhanna; Laura J Delong; Hany F Aziz
Journal:  J Perinatol       Date:  2003-10       Impact factor: 2.521

9.  The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor.

Authors:  Bo Hyun Yoon; Roberto Romero; June-Hee Lim; Soon-Sup Shim; Joon-Seok Hong; Jae-Yoon Shim; Jong Kwan Jun
Journal:  Am J Obstet Gynecol       Date:  2003-10       Impact factor: 8.661

10.  Failure of erythromycin to eliminate airway colonization with ureaplasma urealyticum in very low birth weight infants.

Authors:  R John Baier; John Loggins; Thomas E Kruger
Journal:  BMC Pediatr       Date:  2003-09-04       Impact factor: 2.125

View more
  162 in total

1.  3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.

Authors:  Jay Lin; Vincent Roy; Liya Wang; Li You; Luigi A Agrofoglio; Dominique Deville-Bonne; Tamara R McBrayer; Steven J Coats; Raymond F Schinazi; Staffan Eriksson
Journal:  Bioorg Med Chem       Date:  2010-03-15       Impact factor: 3.641

2.  Simultaneous detection and identification of STI pathogens by multiplex Real-Time PCR in genital tract specimens in a selected area of Apulia, a region of Southern Italy.

Authors:  Raffaele Del Prete; Luigi Ronga; Mirella Lestingi; Grazia Addati; Umberto Filippo Angelotti; Domenico Di Carlo; Giuseppe Miragliotta
Journal:  Infection       Date:  2017-03-04       Impact factor: 3.553

3.  Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.

Authors:  Hazem E Hassan; Ahmed A Othman; Natalie D Eddington; Lynn Duffy; Li Xiao; Ken B Waites; David A Kaufman; Karen D Fairchild; Michael L Terrin; Rose M Viscardi
Journal:  J Clin Pharmacol       Date:  2010-11-23       Impact factor: 3.126

4.  Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Tae-Jung Sung; Li Xiao; Lynn Duffy; Ken B Waites; Kirsty L Chesko; Rose M Viscardi
Journal:  Pediatr Infect Dis J       Date:  2011-05       Impact factor: 2.129

5.  Ureaplasma urealyticum meningitis in an adult patient.

Authors:  Walter Geissdörfer; Günter Sandner; Stefan John; André Gessner; Christoph Schoerner; Klaus Schröppel
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

6.  Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.

Authors:  Ken B Waites; D M Crabb; Lynn B Duffy
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

7.  Bacterial etiology of sexually transmitted infections at a STI clinic in Ghana; use of multiplex real time PCR.

Authors:  Augustina A Sylverken; Ellis Owusu-Dabo; Denis D Yar; Samson P Salifu; Nana Yaa Awua-Boateng; John H Amuasi; Portia B Okyere; Thomas Agyarko-Poku
Journal:  Ghana Med J       Date:  2016-09

8.  Molecular epidemiology of selected sexually transmitted infections.

Authors:  Hamid Jalal; Andrew Delaney; Neil Bentley; Christopher Sonnex; Christopher A Carne
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

9.  Integrated morphologic and molecular analysis of Trichomonas vaginalis, Mycoplasma hominis, and human papillomavirus using cytologic smear preparations.

Authors:  I Nikas; A Hapfelmeier; M Mollenhauer; D Angermeier; M Bettstetter; R Götz; M Schmidmayr; V Seifert-Klauss; A Muckenhuber; U Schenck; Gregor Weirich
Journal:  Parasitol Res       Date:  2018-03-17       Impact factor: 2.289

10.  Mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny.

Authors:  Kyriaki Markoullis; Diana Bulian; Gabriele Hölzlwimmer; Leticia Quintanilla-Martinez; Katrin-Janine Heiliger; Horst Zitzelsberger; Hagen Scherb; Josef Mysliwietz; Cord C Uphoff; Hans G Drexler; Thure Adler; Dirk H Busch; Jörg Schmidt; Esther Mahabir
Journal:  Transgenic Res       Date:  2008-09-26       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.